Japanese Entertainment Stock News

Max (TSE:6454) is back in focus after raising its earnings and dividend forecasts, with higher targets for net sales, operating profit, profit attributable to shareholders, and annual dividends for the year ending March 31, 2026. See our latest analysis for Max. The guidance upgrade and higher dividend forecast come after a strong run, with a 1-year total shareholder return of 62.2% and a 5-year total shareholder return of 374.01%. The 30-day share price return of 5.41% suggests momentum has...

In early March 2026, Kyowa Kirin Co., Ltd. announced it would discontinue all clinical trials of rocatinlimab, an investigational anti-OX40 antibody for moderate-to-severe atopic dermatitis, prurigo nodularis, and asthma, following a planned safety review conducted with partner Amgen. The decision was driven by emerging malignancy signals, including confirmed and suspected cases of Kaposi’s sarcoma that, despite low overall incidence, raised plausible mechanistic concerns about OX40 pathway...

If you are wondering whether YONEX is still reasonably priced after its strong run, this article will walk through what the current share price could mean for long term investors. YONEX last closed at ¥3,485, with returns of a 1.8% decline over the past week, a 3.9% decline over the past month, a 3.6% gain year to date, 48.4% over the last year and 179.6% over three years, which naturally raises questions about how much of the story is already reflected in the price. Recent coverage of YONEX...

Resona Holdings, Inc. recently approved changes to its top leadership, appointing long-time insider Shinichiro Isa as Deputy President, Representative Executive Officer, Group CFO and Group CDO, and elevating Nobuki Iwadate to Group Chief Human Resources Officer, Deputy President and Representative Executive Officer, effective April 1, 2026. The concentration of financial, digital and human capital oversight in the hands of two experienced internal leaders may meaningfully influence how...

A UK parliamentary committee has increased pressure on Fujitsu (TSE:6702), criticising its lack of financial contribution to the nearly £1.5b Post Office Horizon redress bill and questioning its ongoing role in public contracts. See our latest analysis for Fujitsu. For context, Fujitsu’s share price return has been weak in the short term, with a 10.33% 1 month and 17.03% year to date decline. However, its 1 year total shareholder return of 21.30% and 3 year total shareholder return above 100%...

Sompo Holdings (TSE:8630) has put governance and trust at the center of its story, updating regulators on reforms around fraudulent auto claims, premium practices, and data leaks that previously challenged its reputation. See our latest analysis for Sompo Holdings. Alongside these governance updates and the Aspen integration in the UK, Sompo Holdings’ ¥5,829 share price comes after a 90 day share price return of 12.10% and a 1 year total shareholder return of 32.92%. The 3 year total...

Event context and recent share performance Asahi Kasei (TSE:3407) shares have been under pressure over the past week and month, with negative 1 day, 7 day, and month returns, even as the past 3 months and 1 year remain positive. See our latest analysis for Asahi Kasei. Short term share price momentum has faded with recent declines, but a 90 day share price return of 15.67% and a 1 year total shareholder return of 60.46% still indicate a strong longer term result. If this mixed picture has you...

In March 2026, Meiji America Inc. announced a US$65,000,000 investment to add Hello Panda production and upgrade equipment at its York, Pennsylvania facility, aiming to lift manufacturing capacity by 50% and support new jobs and local partnerships. Bringing Hello Panda production onshore to York could tighten Meiji’s North American supply chain and deepen collaboration with major U.S. retailers. We’ll now consider how this new Hello Panda capacity in York may influence Meiji Holdings’...

Nomura Research Institute (TSE:4307) has put leadership changes and a subsidiary merger at the center of its latest corporate update. These moves could shape how you think about the stock’s stability and long term direction. See our latest analysis for Nomura Research Institute. At a share price of ¥4,305.0, Nomura Research Institute has a 1 day share price return of 1.6% and a 30 day share price return of 2.01%. Its 90 day share price return of a 30.28% decline and year to date share price...

Helium supply shock puts Iwatani in focus Disruptions at Qatar's natural gas facilities linked to the Iran conflict have pushed helium prices higher, putting Iwatani (TSE:8088) at the center of a supply chain stress test for industrial gas markets. See our latest analysis for Iwatani. Iwatani's share price has reacted quickly to the helium shock, with a 1-day share price return of 7.58% and a 90-day share price return of 18.32%. The 1-year total shareholder return of 31.92% points to momentum...

Why Aichi Financial Group Stock Is Back in Focus After Its Governance Shakeup Aichi Financial Group (TSE:7389) has moved into the spotlight after its board approved a broad reorganization of compliance, risk, sales, and markets functions, alongside significant board and executive lineup changes. These shifts, which start from April 2026 and run through June 2026, are designed to tighten integration between Aichi Financial Group, Aichi Bank, and the group leasing subsidiary while reshaping...

Event context and recent share performance NSK (TSE:6471) shares have come under pressure recently, with a 1 day return of 1.39% and a 6% decline over the past week, adding to a roughly 9.8% pullback over the past month. See our latest analysis for NSK. While the recent 30 day share price return of a 9.8% decline suggests fading short term momentum, the 90 day share price return of 21.86% and 1 year total shareholder return of 87.69% point to a much stronger longer term picture. If NSK’s...

Why February’s trading update matters for Tsuruha Holdings (TSE:3391) Tsuruha Holdings (TSE:3391) caught investor attention after its February 2026 update showed all store net sales year-on-year growth of 4.8% and existing store growth of 4.0%, alongside store openings and closures. For a drugstore operator focused on prescription and retail sales, this combination of sales growth, network reshaping with 12 store openings and 17 closures, and support from dispensing pharmacy operations raises...

Why SBI Holdings (TSE:8473) just moved its dividend goalposts SBI Holdings (TSE:8473) has raised its year end dividend forecast to ¥75 per share and highlighted a completed ¥50b share buyback, following a board decision tied to profits in its Financial Services Business. See our latest analysis for SBI Holdings. The updated dividend and completed ¥50b buyback come after a weaker run in the share price, with a 30 day share price return of 17.6% and a year to date return of 14.26%. This...

Kyoto Financial Group Inc (TSE:5844) has drawn investor attention after sharply raising its earnings guidance, funded by large gains on equity sales, and pairing that move with a special dividend and expanded share buyback plan. See our latest analysis for Kyoto Financial GroupInc. The flurry of guidance upgrades, special dividend plans and the expanded buyback has coincided with strong recent momentum, with a 30 day share price return of 15.21% and a 1 year total shareholder return of...

Governance dispute focuses attention on Kobayashi Pharmaceutical Oasis Management’s public campaign against Kobayashi Pharmaceutical (TSE:4967) and its move to a Company with an Audit and Supervisory Committee has pushed the company’s governance structure and board oversight firmly into the spotlight for shareholders. See our latest analysis for Kobayashi Pharmaceutical. The governance dispute has arrived after a period where the 90 day share price return of 7.41% contrasts with a weaker 3...

In March 2026, MonotaRO Co., Ltd. reported its preliminary non-consolidated sales for February 2026, with monthly sales of ¥28,454 million compared with ¥24,262 million a year earlier. This year-on-year increase in monthly sales highlights how MonotaRO’s recent trading performance may be influencing investor perceptions of its business momentum. We’ll now examine how this year-on-year sales growth in February shapes MonotaRO’s broader investment narrative and key areas of focus. Rare earth...

Why Zeon (TSE:4205) is on investors’ radar today Recent share performance at Zeon (TSE:4205), including a negative 1 day move and weaker week and month returns, has prompted closer attention to how its fundamentals line up with current pricing. See our latest analysis for Zeon. While the 1 day and 1 month share price returns are in decline, the 90 day share price return of 4.86% and 1 year total shareholder return of 28.72% point to longer term momentum that contrasts with recent softness. If...

Yamaha Motor stock triggered review Yamaha Motor (TSE:7272) shares have been relatively flat over the past month after a weaker past 3 months, prompting a closer look at how recent returns line up with the company’s current fundamentals. See our latest analysis for Yamaha Motor. At around ¥1,107, Yamaha Motor’s recent 1-day and 7-day share price declines, alongside a weaker 90-day share price return, contrast with its positive 3-year and 5-year total shareholder returns. This suggests that...

Why IHI (TSE:7013) is on investors’ radar today IHI (TSE:7013) has recently drawn attention after a period of mixed share performance, with a negative month but a strong past 3 months and 1 year total return. This has prompted fresh questions about how its current valuation lines up with fundamentals. See our latest analysis for IHI. At a share price of ¥3,734.0, IHI has recently seen a 10.02% 1 month share price decline, following a strong 27.42% 3 month share price return and a very large 5...

Earlier in March 2026, Ono Pharmaceutical Co., Ltd. and Congruence Therapeutics expanded their drug discovery collaboration to cover neurology and immunology, giving Ono exclusive worldwide option rights over any resulting small molecule candidates and tying Congruence’s economics to upfront, milestone and tiered royalty payments. This move extends Ono’s use of Congruence’s Revenir computational platform beyond oncology into areas of significant unmet medical need, potentially reshaping the...

Casio ComputerLtd (TSE:6952) is back on investor radars after its recent share price moves, with returns showing a mix of setbacks over the past month, as well as gains over the past 3 months and year. See our latest analysis for Casio ComputerLtd. At a share price of ¥1,418.0, Casio ComputerLtd has recently seen a 30 day share price return decline of 13.17%, while the 90 day share price return of 11.09% and 1 year total shareholder return of 18.85% suggest momentum has generally been...

Japan Steel Works (TSE:5631) has moved to expand its production capacity after increased demand from the nuclear energy sector, putting its industrial machinery and engineering businesses more directly in focus for investors. See our latest analysis for Japan Steel Works. The capacity expansion news comes after a strong run in the shares. The current share price is ¥10,040 and the 90 day share price return is 21.93%, building on a 1 year total shareholder return of 70.69%. The 3 year total...

Sojitz (TSE:2768) has moved into focus after fresh rare earths news linked to Lynas Rare Earths and Japan Australia Rare Earths, as investors reassess the trading house’s role in Japan’s supply security. See our latest analysis for Sojitz. Against this backdrop, Sojitz’s ¥6,256 share price sits after a 1 day share price return of 0.9% and a 90 day share price return of 24.6%. The 1 year total shareholder return of 96.3% points to strong momentum as investors react to its rare earths...